SUSANA TORRADO DURÁN-rekin lankidetzan egindako argitalpenak (25)

2017

  1. Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 529, Núm. 1-2, pp. 381-390

2016

  1. New Multi-Particle Systems for Colon-Targeted Meloxicam

    Journal of Applied Pharmacy, Vol. 8, Núm. 3, pp. 1-3

2015

  1. Novel solid dispersions of benznidazole: Preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system

    Experimental Parasitology, Vol. 149, pp. 84-91

2014

  1. Development of novel benznidazole formulations: Physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease

    International Journal of Pharmaceutics, Vol. 472, Núm. 1-2, pp. 110-117

  2. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

    Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479

2012

  1. The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treat-ments

    Current Drug Metabolism, Vol. 13, Núm. 9, pp. 1303-1312

2011

  1. Changed crystallinity of mebendazole solid dispersion: Improved anthelmintic activity

    International Journal of Pharmaceutics, Vol. 403, Núm. 1-2, pp. 23-28

2004

  1. Chitosan-poly(acrylic) acid polyionic complex: In vivo study to demonstrate prolonged gastric retention

    Biomaterials, Vol. 25, Núm. 5, pp. 917-923

2003

  1. Interpolymer complexes of poly(acrylic acid) and chitosan: Influence of the ionic hydrogel-forming medium

    Biomaterials, Vol. 24, Núm. 8, pp. 1459-1468

2002

  1. Characterization of physical state of mannitol after freeze-drying: Effect of acetylsalicylic acid as a second crystalline cosolute

    Chemical and Pharmaceutical Bulletin, Vol. 50, Núm. 5, pp. 567-570

1999

  1. Preparation, dissolution and characterization of praziquantel solid dispersions

    Chemical and Pharmaceutical Bulletin, Vol. 47, Núm. 11, pp. 1629-1633

1998

  1. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: The influence of the dose-regime

    Veterinary Parasitology, Vol. 75, Núm. 2-3, pp. 209-219

  2. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods

    International Journal of Pharmaceutics, Vol. 166, Núm. 1, pp. 55-63

1997

  1. A novel formulation of albendazole solution: Oral bioavailability and efficacy evaluation

    International Journal of Pharmaceutics, Vol. 156, Núm. 2, pp. 181-187

  2. Improvement of albendazole efficacy against enteral, but not against parenteral stages of trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone

    Chemotherapy, Vol. 43, Núm. 6, pp. 430-435

1996

  1. Egg albumin microaggregates containing colistin for oral administration: Organoleptic characteristics

    Drug Development and Industrial Pharmacy, Vol. 22, Núm. 5, pp. 451-456

  2. Formulation parameters of albendazole solution

    International Journal of Pharmaceutics, Vol. 140, Núm. 1, pp. 45-50

  3. Preparation, dissolution and characterization of albendazole solid dispersions

    International Journal of Pharmaceutics, Vol. 140, Núm. 2, pp. 247-250

1995

  1. Effect of dissolution profile and (-)-α-bisabolol on the gastrotoxicity of acetylsalicylic acid

    Pharmazie, Vol. 50, Núm. 2, pp. 141-143

1994

  1. AAS formulations: Dissolution profile and gastrotoxicity

    Proceedings of the Controlled Release Society